Exonics to use CRISPR in an effort to treat majority of DMD boys – FierceBiotech
FierceBiotech |
Exonics to use CRISPR in an effort to treat majority of DMD boys
FierceBiotech Exonics Therapeutics has won $5 million in seed funding toward its goal of using cutting-edge new gene editing technology to help correct the majority of DMD mutations in young boys. The new CRISPR/Cas9 tech, which only began human testing in China … Exonics Therapeutics Launches with Funding from CureDuchenne Ventures to Advance CRISPR/Cas9 Therapy for … CureDuchenne Ventures Invests in New Gene Editing Company Exonics Therapeutics to Advance CRISPR/Cas9 … |
